Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-018265
Filing Date
2020-07-02
Accepted
2020-07-02 16:07:38
Documents
2
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1598
2 EX-24 DOCUMENT attachment1.htm EX-24 3738
  Complete submission text file 0000899243-20-018265.txt   6636
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Spellman David A (Reporting) CIK: 0001733204 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 201009319